UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2026
Commission File Number 001-42254
Rezolve AI plc
(Translation of registrant’s name into English)
21 Sackville Street,
London, W1S 3DN
United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
Securities Purchase Agreements
On January 20, 2026, Rezolve AI plc (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (together, the “Purchasers”), providing for the issuance and sale by the Company of an aggregate of 62,500,000 shares (the “Shares”) of the Company’s ordinary shares, nominal value £0.0001 par value per share (the “Ordinary Shares”). The Shares were offered and sold for a purchase price of $4.00 per Share, for gross proceeds of $250.0 million, before deducting placement agent fees and other offering expenses.
The Shares were offered and sold pursuant to an effective registration statement on Form F-3 (Registration No. 333-291842) (the “Registration Statement”) filed with the U.S. Securities and Exchange Commission and a related prospectus supplement (the “Offering”).
The Company intends to use the net proceeds from the offering for accelerated investment into its sale organization, potential accretive M&A opportunities and general corporate and working capital purposes.
The Offering is expected to close on January 21, 2026, subject to the satisfaction of customary closing conditions.
Pursuant to the Purchase Agreement, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed issuance of any Ordinary Shares or Ordinary Share equivalents, or file any registration statement or any amendment or supplement thereto, for a period of 30 days after the closing of the Offering, subject to certain exceptions.
The Company has also engaged Cantor Fitzgerald & Co., Roth Capital Partners and Northland Capital Markets as financial advisors in connection with the Offering.
Placement Agent Agreement
The Company also entered into a Placement Agent Agreement (the "Placement Agent Agreement") on January 20, 2026, with A.G.P./Alliance Global Partners (the “Lead Placement Agent”) and Titan Partners Group LLC, a division of American Capital Partners, LLC ("Titan" and, together with the Lead Placement Agent, the "Placement Agents"), pursuant to which the Placement Agents served as the exclusive placement agents in connection with the Offering. The Company agreed to pay the Placement Agents a fee in cash equal to 5.0% of the aggregate gross proceeds from the sale of the Shares. The Company also agreed to reimburse the Lead Placement Agent for out-of-pocket expenses, including the reasonable fees of legal counsel not to exceed $120,000 as well as non-accountable expenses not to exceed $10,000.
The Purchase Agreement and the Placement Agent Agreement contain customary representations, warranties, and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties, and termination provisions. The representations, warranties and covenants contained therein were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties thereto, and may be subject to limitations agreed upon by the contracting parties.
The foregoing descriptions of the Purchase Agreement and the Purchase Agreement do not purport to be complete and are qualified in their entirety by reference to the full text thereof, which are included as Exhibits 10.1 and 10.2 hereto, respectively, to this Report of Foreign Private Issuer on Form 6-K (this "Form 6-K") and are incorporated herein by reference.
A copy of the legal opinion of Taylor Wessing LLP relating to the validity of the issuance and sale of the Shares in the Offering is filed as Exhibit 5.1 to this Form 6-K and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.
Press Release
On January 20, 2026, the "Company" issued a press release regarding its entry into the Purchase Agreement with the Purchasers named therein providing for the issuance and sale by the Company of an aggregate of 62,500,000 shares. A copy of the press release is furnished as Exhibit 99.1 to this Form 6-K and is incorporated herein by reference.
The information included in this Form 6-K under the captions "Securities Purchase Agreement" and "Placement Agent Agreement" (including Exhibits 10.1, 10.2 and 5.1) are hereby incorporated by reference into the Company’s Registration Statements on Forms F-3 (File Nos. 333-290523, File No. 333-290639, and File No. 333-291842) and Form S-8 (File No. 333-284174 and File No. 333-292308) (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this Form 6-K is furnished.
|
|
|
|
Exhibit No. |
Description |
5.1 |
Opinion of Taylor Wessing |
10.1 |
Form of Securities Purchase Agreement |
10.2 |
Placement Agent Agreement, dated January 20, 2026, between Rezolve AI plc, A.G.P/Alliance Global Partners and Titan Partners Group LLC |
99.1 |
Press Release dated January 20, 2026 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 20, 2026
|
|
|
|
|
|
By: |
|
/s/ Daniel Wagner |
Name: |
|
Daniel Wagner |
Title: |
|
Chief Executive Officer and Director |
Exhibit 5.1
20 January 2026
Rezolve AI PLC
21 Sackville Street London W1S 3DN
United Kingdom
Re: Rezolve AI PLC
Dear Addressee
1.1We have acted as English legal advisers to Rezolve AI PLC (the “Company”), a public limited company incorporated in England and Wales with company number 14573691 and with its registered office at 21 Sackville Street, London, United Kingdom, W1S 3DN (the “Company”), in relation to matters of English law only, pursuant to that Securities Purchase Agreement entered into by the Company and the purchasers signatories thereto (the "Purchasers") on 20 January 2026 (the "Securities Purchase Agreement") and the Placement Agent Agreement entered into by the Company and A.G.P./Alliance Global Partners and Titan Partners Group LLC, (a division of American Capital Partners LLC) (the "Placement Agents") on 20 January 2026 (the "Placement Agent Agreement", and together with the Securities Purchase Agreement, the "Transaction Documents") in connection with the Company’s registered direct offering (the “Offering”) of 62,500,000 of the Company’s ordinary shares of £0.0001 nominal value each (the “Ordinary Shares”). Except as otherwise defined herein, capitalized terms used have the respective meanings given to them in the Securities Purchase Agreement. Terms used herein but not defined herein shall have the meanings ascribed to such terms in the Securities Purchase Agreement.
In connection with the Offering, the Company has filed with the securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), a prospectus supplement, dated on or about 20 January 2026 (the “Prospectus Supplement”) relating to a Registration Statement on Form F-3 (File No. 333-291842) filed with the Commission on November 28, 2025, under the Securities Act and declared effective by the Commission on December 19, 2025 (the “Registration Statement”) and has issued or is to issue a Form 6-K (the "Form 6-K") on or about the date hereof in connection with the Transaction and the Prospectus Supplement.
1.2Pursuant to the terms of the Securities Purchase Agreement, the Company has agreed to issue, and the Purchasers, severally and not jointly, have agreed to purchase, an aggregate of 62,500,000 Ordinary Shares in the capital of the Company (the "Relevant Shares") (the "Transaction").
2.1This opinion letter is being furnished in connection with the Prospectus Supplement relating to the Registration Statement to be filed with the Commission on the date hereof under the Securities Act and the Rules. We have taken instruction in this regard solely from the Company.
2.2The provision of this letter is not to be taken as implying that we owe any duty of care to anyone, including the Company, in relation to the content or the commercial and financial implications of the Prospectus Supplement or the Registration Statement.
2.3Nothing stated in this letter shall create the relationship of solicitor and client between us and anyone other than the Company.
2.4For the purposes of issuing this opinion, we have received a draft copy of the Prospectus Supplement and examined the following documents:
(a)a copy of the Securities Purchase Agreement;
(b)the Placement Agent Agreement;
(c)the Registration Statement;
(d)the base prospectus, dated November 28, 2025, included as part of the Registration Statement,
(e)the Prospectus Supplement;
(g)the articles of association of the Company that were adopted and effective from the date of the re-registration of the Company from a private limited company to a public limited company on 28 March 2025 (the "Articles");
(h)a copy of the minutes of the meeting of the board of directors of the Company ("Board") passed on 19 January 2026 approving the entering into, inter alia, of the Securities Purchase Agreement and the issue and allotment of the Relevant Shares in accordance with the terms of the Securities Purchase Agreement (the "Board Resolutions") and for the purpose of this opinion we assume that all the resolutions in the Board Resolutions have been duly and validly passed; and
(i)a copy of the shareholder resolutions of the Company dated 13 January 2026 approving, inter alia, the authorisation (the "Authorisation") for the directors of the Company to allot fully paid ordinary shares of £0.0001 each in the capital of the Company ("Ordinary Shares") (or to grant rights to subscribe for or to convert any security into Ordinary Shares), and the disapplication of pre-emptive rights for such allotment, in relation to additional shares having an aggregate nominal amount of up to £200,000 (the "Shareholder Resolutions"),
(the Shareholder Resolutions, together with the Board Resolutions, being the "Corporate Approvals").
(a)an online search of the information available on file at Companies House in respect of the Company conducted on 20 January 2026 at 10:29 a.m. (London time); and
(b)a telephone enquiry of the Central Registry of Winding Up and Administration Petitions on 20 January 2026 at 10:38 a.m. (London time) which revealed that as at that date no petition has been lodged for the winding-up of the Company.
We assume that the information obtained in that search and enquiry was accurate, did not fail to disclose any relevant matter and that a further search or enquiry would not reveal any change or new matter which would affect this opinion.
2.6In relation to insolvency proceedings, the search and enquiry referred to in paragraph 2.5 relate only to insolvency proceedings begun in England and are not conclusively capable of disclosing whether an interim or final administration order or winding up order has been made or resolution passed for the winding up of a company, whether a moratorium is in force for the company or whether a receiver, administrative receiver, administrator or liquidator has been appointed (or petition made for the winding up) of a company.
2.7In particular, notice of these matters may not yet have been filed with the Registrar of Companies (or if filed, may not yet be publicly available) and notice of a petition for winding up is not required to be filed with the Registrar. In addition, details of a petition for winding up may not be entered on the Central Registry of Winding Up and Administration Petitions immediately (or in the case of a petition presented to a County Court, may not have been notified for entry on the Central Registry at all) and any response to an enquiry would only relate to the last six months before the enquiry.
3.Basis of opinion, assumptions and qualifications
3.1The opinion set out in paragraph 4 relates solely to English law at the date of this letter as it appears from published legislation and fully reported cases before that date.
3.2We have not investigated the laws of any country other than England and we assume that no foreign law affects any of the opinions stated in this letter.
3.3This letter does not relate to English conflict of laws rules.
3.4We do not undertake or accept any obligation to update this letter and/or the opinions given in it to reflect subsequent changes in English law or factual matters.
3.5We express no opinion on the impact of any rules, regulations or requirements of the NASDAQ Stock Market LLC or the rules and regulations adopted by the SEC.
3.6We express no opinion in this letter on the laws of any jurisdiction other than England. It is assumed that no foreign law which may apply to the matters contemplated by the Transaction, the Transaction Documents the Registration Statement, the Supplemental Prospectus, the Company, any document or any other matter contemplated by any document would or might affect this letter and/or the opinions given in it.
3.7For the purposes of this opinion, we have not examined:
(a)any contract, other than those set out in paragraph 2.4 which may affect the validity or enforceability of the contracts set out in paragraph 2.4; or
(b)any of the corporate or other records of the Company (apart from those set out in paragraph 2.4 or revealed by the searches mentioned in paragraph 2.5),
nor (apart from those mentioned in paragraph 2.5) have we made any other search or enquiry concerning the Company.
3.8For the purposes of our opinion we have also assumed:
(a)the Registration Statement, as amended and supplemented (including by the Supplemental Prospectus), being or becoming effective under the Securities Act and continuing to be effective;
(b)the aggregate nominal value of Ordinary Shares allotted and issued or agreed to be allotted and issued under the Authorisation granted pursuant to the Shareholder Resolutions together with those to be allotted and issued as contemplated by the Securities Purchase Agreement and as referred to in the
Registration Statement as supplemented by the Supplemental Prospectus and those shares already allotted or agreed to be allotted pursuant to the Corporate Approvals not being greater than the aggregate nominal value of £200,000 specified in the Authorisation in the Shareholder Resolutions;
(c)the allotment and issue of Relevant Shares to either GTU Ops Inc (or another depositary nominee of Computershare Trust Company. N.A.) or Cede & Co. (or another nominee of The Depositary Trust Company) for the ultimate benefit of a party shall constitute due satisfaction of the Company's obligations to issue and allot Ordinary Shares to such party under the applicable documents set out in paragraph 2.4;
(d)the Transaction Documents and the transactions contemplated thereby have been effected in accordance with all requirements of and the Company has complied with the requirements of NASDAQ, the Commission and DTC;
(e)the receipt in full of payment for the Relevant Shares of not less than the aggregate nominal value plus the applicable premium for such Relevant Shares and the agreement by the allottees to become members of the Company;
(f)that the Corporate Approvals and any additional board and shareholder resolutions required pursuant to the terms of the Companies Act 2006 (the “Companies Act”) or any other applicable law and/or the articles of the Company (as in force from time to time) were or will be (as appropriate) each duly passed by written resolution or at a meeting which was or will be duly convened and held in accordance with all applicable laws and regulations; that in particular, but without limitation, a duly qualified quorum of directors or, as the case may be, shareholders was or will be present in each case throughout any such meeting and voted or vote in favour of the resolutions; and that in relation to each meeting of the Board, each provision contained in the Companies Act or the articles of the Company (as in force from time to time) relating to the declaration of the directors’ interests or the power of the interested directors to vote and to count in the quorum was or will be duly observed;
(g)valid entries have been or will be made in relation to the allotment and issue of the Relevant Shares in the books and registers of the Company;
(h)that all representations and warranties in the Transaction Documents are true, accurate and complete in all respects;
(i)where a document submitted to us is not fully executed or dated, that the Company holds a fully executed and dated version of the document (or alternatively the Company holds all counterpart execution versions of the document);
(j)the genuineness of all signatures on, and the authenticity and completeness of, all documents submitted to us;
(k)the Articles remain in full force and effect, and no alteration has been made or will be made to such articles of association prior to the date of allotment and issue of the Relevant Shares (the “Allotment Date”);
(l)on the Allotment Date, the Company will comply or has complied with all applicable laws as to any offering of and as to the allotment and issue of the Relevant Shares and the Company has received (or for Ordinary Shares to be issued will receive) such amounts as are necessary to fully pay the nominal value of the Relevant Shares and any applicable share premium;
(m)the Board Resolutions provided to us in connection with the giving of the opinions in this letter reflect a true record of the proceedings described in them in duly
convened, constituted and quorate meetings in which all constitutional, statutory and other formalities were or will be duly observed, and the resolutions set out in the minutes were or will be validly passed and have not been and will not be revoked or varied and remain in full force and effect and will remain so as at the Allotment Date;
(n)in respect of the Board Resolutions (i) in passing such resolution the directors of the Company were or will be acting in good faith, (ii) the transactions and other matters referred to in the Board Resolutions were or are to be entered into and effected by the Company for the purpose of carrying on its business, (iii) at the time such transactions or matters were or (as the case may be) are to be entered into or effected the Board had or (as the case may be) will have reasonable grounds for believing that the transactions or matters would or (as the case may be) will promote the success of the Company for the benefit of its members as a whole, and (iv) the Board exercised or exercises their powers in connection with the transactions or matters in accordance with all applicable laws;
(o)the resolutions set out in the Corporate Approvals and/or such other board or shareholder resolutions that are otherwise obtained and/or required by the Company at a later date to, inter alia, validly authorise the issuance of all Relevant Shares were or will be validly passed and have not been and will not be revoked or varied and remain in full force and effect and will remain so as at the Allotment Date;
(p)as at the Allotment Date, the directors of the Company had or shall have sufficient powers conferred on them to allot the Relevant Shares and to grant rights to subscribe for Relevant Shares (as applicable) under section 551 (Power of directors to allot shares etc: authorisation by company) of the Companies Act and under section 570 (Disapplication of pre-emption rights: directors acting under general authorisation) of the Companies Act as if section 561 of the Companies Act did not apply to such allotment or grant and the Company has not issued (or purported to issue) and shall not issue (or purport to issue) Relevant Shares and has not granted (or purported to grant) and shall not grant rights (or purport to grant rights) in excess of such powers or in breach of any other limitation on their powers to issue shares or grant rights;
(q)in relation to the allotment and issue of the Relevant Shares, the directors of the Company have acted and will act in the manner required by section 172 of the Companies Act (Duty to promote the success of the Company), and there has not been and will not be any bad faith, breach of trust, fraud, coercion, duress or undue influence on the part of any of the directors of the Company and such directors exercised their powers in accordance with all other statutory duties under the Companies Act and English common law;
(r)as at the Allotment Date, any authority granted pursuant to the articles (in force from time to time) or the Shareholder Resolutions or otherwise by the Company’s shareholders remained or will remain unutilised to the extent necessary to permit the allotment and issue of the Relevant Shares;
(s)each of the signed documents examined by us has been duly executed and, where applicable, delivered on behalf of the Company and each natural person executing such documents has sufficient legal capacity to enter into such documents and perform the transactions contemplated herein;
(t)that any person who signed a document (which we have reviewed for the purposes of the opinion given in this letter) as a witness was physically present at the time when the signatory signed such document;
(u)the conformity to originals of all documents submitted to us as copies of originals and the authenticity of the originals;
(v)that the documents and records referred to in paragraphs 2.4 and 2.5 are accurate and complete;
(w)that except as disclosed in the documents referred to in paragraph 2.4, and the search and enquiry referred to in paragraph 2.5:
(i)no arrangement or composition with or for the benefit of the creditors of the Company (including a voluntary arrangement as defined in the Insolvency Act 1986) has been entered into or proposed;
(ii)no moratorium has come into force in respect of the Company under Part A1 of the Insolvency Act 1986;
(iii)no receiver or administrative receiver has taken possession of or being appointed over nor has any mortgagee, chargee or other encumbrancer taken possession of the whole or any material part of the assets of the Company;
(iv)neither the Company nor its directors nor the holder of a qualifying floating charge (as defined in Schedule B1 to the Insolvency Act 1986) has given notice of his, her, their or its intention to appoint an administrator in accordance with paragraphs 18 or 26 of Schedule B1 to the Insolvency Act 1986;
(v)neither the Company nor its directors nor any of their creditors nor the holder of a qualifying floating charge (as defined in Schedule B1 to the Insolvency Act 1986) has made an application to the court for the appointment of an administrator of the Company;
(vi)no administrator has been appointed of the Company under paragraphs 14 or 22 of Schedule B1 to the Insolvency Act 1986 or otherwise; and
(vii)no petition has been presented nor a resolution been passed nor has an order been made for the administration or the winding-up, bankruptcy or dissolution of the Company;
(x)as at the Allotment Date, the Company has not taken nor will take any corporate or other action nor have any steps been taken or legal proceedings been started nor steps be taken or legal proceedings started against the Company for the liquidation, winding up, dissolution, reorganisation or bankruptcy of, or for the appointment of a liquidator, receiver, trustee, administrator, administrative receiver or similar officer of, the Company or all or any of its assets (or any analogous proceedings in any jurisdiction) and the Company was not or is not unable to pay its debts as they fall due within the meaning of section 123 of the Insolvency Act 1986, and was not and will not become unable to pay its debts within the meaning of that section as a result of any of the transactions contemplated herein, was not and is not insolvent and has not been and will not be dissolved or declared bankrupt;
(y)all facts which are stated in any official public record, including the search and enquiry referred to in paragraph 2.5, or other document or information supplied by a public official are correct; in particular that all documents, forms and notices which should have been delivered to the Registrar of Companies in respect of the Company have been so delivered, that information revealed by the search and enquiry referred to in paragraph 2.5 was complete and accurate in all respects and has not, since the time of the search and enquiry, been altered and that the results of the search and enquiry will remain complete and accurate as at the Allotment Date;
(z)that each of the Transaction Documents and the transactions to be effected
pursuant to them (and any other documents related thereto) (including the Transaction) constitute legal, valid, binding and enforceable obligations of each of the parties thereto under all applicable laws and that there are no provisions of the laws of any jurisdiction outside England which would be contravened by the execution or delivery of the documents in paragraph 2.4 and that insofar as any obligation under any such documents falls to be performed or any action falls to be taken in any jurisdiction outside England, the performance of that obligation or taking of that action will not be unlawful by virtue of the laws of that jurisdiction;
(aa) that no event analogous to any of the events mentioned in paragraph 3.8(w) or any other insolvency procedure has occurred in respect of the Company in a country other than England and that no steps have been taken to subject either of them to such a procedure;
(bb) none of the activities of the Company are such that the Transaction or the performance of any of the obligations under the Transaction Documents would amount to a "notifiable acquisition" for the purpose of the UK National Security and Investment Act 2021;
(cc) to extent that the entry into of a document in paragraph 2.4 by the Company constitutes or constituted a regulated activity for the purposes of the Financial Services and Markets Act 2000 the Company was at the relevant time and will be at all relevant times in compliance with all applicable requirements of that Act and any regulations or rules made under that Act;
(dd) that there are or were no written or oral representations made in connection with the documents in paragraph 2.4 which have not been disclosed to us;
(ee) that there are or were no written or oral agreements modifying the terms of the documents in paragraph 2.4 which have not been disclosed to us;
(ff) that there is no other information known to the Company or its employees, agents or sub-contractors and not disclosed to us which would affect the opinions expressed below; and
(gg) that there has been no change in the facts and matters disclosed in the search and enquiry referred to in paragraph 2.5 since we made them.
4.1On the basis of the above assumptions (and subject to the reservations and qualifications set out herein and to any matters not disclosed to us) we are of the opinion that as at the time the Relevant Shares are registered in the name of the relevant recipient in accordance with the terms of the Securities Purchase Agreement, the Relevant Shares will have been duly and validly authorized and issued, fully paid or credited as fully paid and be non-assessable. The term “non-assessable”, which has no recognised meaning in English law, for the purposes of this opinion means that, under the Companies Act 2006, the Articles and any resolution of the Company or its board of directors (or any committee thereof) approving the issue of such Relevant Shares, no present or future holder of such Relevant Shares will be subject to personal liability, by reason of being such a holder, for additional payments or calls for further funds by the Company or any other person..
5.1We express no opinion as to any agreement, instrument or other document other than as specified in this letter or as to any liability to tax or duty which may arise or be suffered as a result of or in connection with the transactions contemplated by the Transaction
Documents or the Registration Statement as supplemented by the Supplemental Prospectus or the Form 6-K.
5.2This letter only applies to those facts and circumstances which exist as at today’s date and we assume no obligation or responsibility to update or supplement this letter to reflect any facts or circumstances which may subsequently come to our attention, any changes in laws which may occur after today, or to inform the addressee of any change in circumstances happening after the date of this letter which would alter our opinion. Our liability under this opinion is limited to $25m. This opinion and any non-contractual obligations arising out of or in relation to this opinion are governed by English law.
6.Disclosure and reliance
6.1This letter is rendered to you for your benefit in connection with the Transaction Documents and the Registration Statement as supplemented by the Supplemental Prospectus. We consent to the filing of this letter as an exhibit to the Supplemental Prospectus and the Form 6-K. We further consent to the incorporation by reference of this letter and consent into any registration statement filed under the Securities Act with respect to the Relevant Shares. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under the Securities Act or the rules and regulations thereunder.
6.2Other than for the purpose set out in the prior paragraph, this letter may not be relied upon, or assigned, for any purpose, without our prior written consent, which may be granted or withheld in our discretion.
Yours faithfully
Taylor Wessing LLP
